Learn More About the PROSERA Study
The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Seralutinib in Pulmonary Arterial Hypertension: Exploring Mechanisms of Reverse Remodeling Versus Vasodilation
